Different anesthetics, same result: unconsciousness by shifting brainwave phase
MIT study finds an easily measurable brain wave shift may be a universal marker of unconsciousness under anesthesia.
MIT study finds an easily measurable brain wave shift may be a universal marker of unconsciousness under anesthesia.
A team of MIT researchers founded Themis AI to quantify AI model uncertainty and address knowledge gaps.
Researchers redesign a compact RNA-guided enzyme from bacteria, making it an efficient editor of human DNA.
MIT researchers developed a new model of memory that includes critical contributions from astrocytes, a class of brain cells.
After six weeks of practicing mindfulness with the help of a smartphone app, adults with autism reported lasting improvements in their well-being.
New evidence suggests sensory stimulation of gamma-frequency brain rhythm may promote broad-based restorative neurological health response.
Study shows how a dopamine circuit enables mice to extinguish fear after a peril has passed, opening new avenues for understanding and potentially treating fear-related disorders.
New type of “state-space model” leverages principles of harmonic oscillators.
Clinical trial finds several outcomes improved for young children when an anesthesiologist observed their brain waves to guide dosing of sevoflurane during surgery.
Upon infection, the C. elegans worm reshuffles the roles of brain cells and flips the functions of some of the chemicals it uses to regulate behavior.
Since an MIT team introduced expansion microscopy in 2015, the technique has powered the science behind kidney disease, plant seeds, the microbiome, Alzheimer’s, viruses, and more.
A quarter century after its founding, the McGovern Institute reflects on its discoveries in the areas of neuroscience, neurotechnology, artificial intelligence, brain-body connections, and therapeutics.
New research on a cytokine called IL-17 adds to growing evidence that immune molecules can influence behavior during illness.
A decade of studies provide a growing evidence base that increasing the power of the brain’s gamma rhythms could help fight Alzheimer’s, and perhaps other neurological diseases.
A new, highly efficient process for performing this conversion could make it easier to develop therapies for spinal cord injuries or diseases like ALS.